Published in Gastroenterology on March 01, 1980
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol (1982) 2.52
Rapid detection of Clostridium difficile toxin in human feces. J Clin Microbiol (1980) 2.33
Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol (1983) 1.89
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut (1983) 1.37
Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol (2003) 1.19
Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut (2004) 1.14
Household pets as a potential reservoir for Clostridium difficile infection. J Clin Pathol (1983) 1.06
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters. Antimicrob Agents Chemother (1987) 1.00
Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother (1992) 1.00
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrob Agents Chemother (1989) 0.92
Antibiotic-associated colitis--the continuing saga. Br Med J (Clin Res Ed) (1981) 0.88
MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation. Infect Immun (2012) 0.85
Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection. PLoS One (2016) 0.85
WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg (2015) 0.85
Analysis of the in vitro interaction between vancomycin and cholestyramine. Antimicrob Agents Chemother (1981) 0.84
An agent-based simulation model for Clostridium difficile infection control. Med Decis Making (2014) 0.84
Fatal pseudomembranous colitis despite eradication of Clostridium difficile. Br Med J (Clin Res Ed) (1981) 0.83
Antimicrobial agent-associated colitis and diarrhea. West J Med (1980) 0.81
The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis. CMAJ (1990) 0.79
Clostridium difficile colitis following treatment with metronidazole and vancomycin. Postgrad Med J (1987) 0.77
Pseudomembranous colitis after treatment with metronidazole. Br Med J (Clin Res Ed) (1981) 0.75
Structural Insights into Substrate Recognition by Clostridium difficile Sortase. Front Cell Infect Microbiol (2016) 0.75
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet (1997) 13.64
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Anaerobic infections. 1. N Engl J Med (1974) 8.02
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Clindamycin-associated colitis. A prospective study. Ann Intern Med (1974) 5.92
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology (1978) 5.91
Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16
Glanders in a military research microbiologist. N Engl J Med (2001) 4.77
Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med (1995) 4.42
Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis (1979) 4.39
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology (1981) 4.04
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93
Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91
Clinical and laboratory observations in Clostridium difficile colitis. Am J Clin Nutr (1980) 3.89
Quantitative bacteriology of the vaginal flora. J Infect Dis (1977) 3.81
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med (2001) 3.75
Management of anaerobic infections. Ann Intern Med (1975) 3.62
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis (1977) 3.62
Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest (1976) 3.34
Anaerobic pleuropulmonary infections. Medicine (Baltimore) (1972) 3.30
Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21
Anaerobic infections (second of three parts). N Engl J Med (1974) 3.18
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med (2001) 3.15
Colitis induced by Clostridium difficile. Rev Infect Dis (1980) 3.15
Anaerobic infections (third of three parts). N Engl J Med (1974) 3.13
Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis (1984) 3.07
Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med (1972) 3.05
Antibiotic-associated pseudomembranous colitis. Rev Infect Dis (1980) 3.02
Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet (2006) 3.02
Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet (1978) 2.87
Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin. J Clin Microbiol (1979) 2.86
Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg (1999) 2.76
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74
Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med (1977) 2.73
Specification of Drosophila hematopoietic lineage by conserved transcription factors. Science (2000) 2.61
Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56
Clindamycin-associated colitis. Review of the clinical spectrum of 47 cases. Am J Dig Dis (1976) 2.52
Controlling chaos in the brain. Nature (1994) 2.48
Anaerobic infections of the lung and pleural space. Am Rev Respir Dis (1974) 2.46
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA (1998) 2.37
Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg (1977) 2.36
Sequence analysis and expression patterns divide the maize knotted1-like homeobox genes into two classes. Plant Cell (1994) 2.33
Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33
Partial purification and characterization of a cytotoxin from Clostridium difficile. Rev Infect Dis (1980) 2.31
Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A (2001) 2.27
Rapid microbiological assay for chloramphenicol and tetracyclines. Antimicrob Agents Chemother (1976) 2.26
Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J Cell Physiol (1982) 2.20
Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol (1989) 2.18
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med (2001) 2.17
Clostridium difficile in gnotobiotic mice. Infect Immun (1980) 2.17
Microsurgical replantation of the avulsed scalp: report of 20 cases. Plast Reconstr Surg (1996) 2.17
Management considerations for an HIV positive dental student. J Dent Educ (1991) 2.14
Bacterial studies of Clindamycin-associated colitis. A preliminary report. Gastroenterology (1975) 2.13
AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med (1991) 2.13
Acidosis in severe childhood malaria. QJM (1997) 2.12
Methods for quantitative vaginal flora studies. Am J Obstet Gynecol (1977) 2.05
Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res (1987) 2.03
Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis (1983) 2.03
Bacteriology of empyema. Lancet (1974) 2.00
Probenecid and zidovudine metabolism. Lancet (1989) 1.99
A gas chromatographic assay for ketamine in human plasma. Anesthesiology (1972) 1.98
Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology (1978) 1.98
The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors. Gastrointest Endosc (1981) 1.97
Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology (1988) 1.93
Unexpected power-law stress relaxation of entangled ring polymers. Nat Mater (2008) 1.91
Myoglobinuria and renal failure associated with typhoid fever. JAMA (1977) 1.91
In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob Agents Chemother (1980) 1.89
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med (2001) 1.89
Is Clostridium difficile endemic in chronic-care facilities? Lancet (1986) 1.88
Anaerobes survive in clinical specimens despite delayed processing. J Clin Microbiol (1976) 1.87
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82
Update on Department of Health and Human Services guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Hopkins HIV Rep (1999) 1.81
The role of the intestinal microflora in experimental colitis. Am J Clin Nutr (1977) 1.80
Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals. J Clin Microbiol (1984) 1.77
Diagnostic features of clindamycin-associated pseudomembranous colitis. N Engl J Med (1974) 1.77
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis (1979) 1.76
Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr (1979) 1.75
Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med (1976) 1.73
Risk and aetiology of diarrhoea at various tourist destinations. Lancet (2000) 1.72
Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology (2010) 1.69
Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. Johns Hopkins Med J (1981) 1.69
Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis (1998) 1.67
Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res (1978) 1.66
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med (2001) 1.55
Comparison of five regimens for treatment of experimental clindamycin-associated colitis. J Infect Dis (1978) 1.54
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest (1995) 1.53
Concepts of fever: recent advances and lingering dogma. Clin Infect Dis (1997) 1.50
Radiologic placement of subcutaneous infusion chest ports for long-term central venous access. AJR Am J Roentgenol (1997) 1.49
The triple threat of aspiration pneumonia. Chest (1975) 1.48
The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg (1997) 1.46